ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer
Recommendation based on DESTINY-Lung02 trial results, which showed Daiichi Sankyo and AstraZeneca’s ENHERTU achieved strong and durable tumor responses in...

Karnataka High Court Quashes BJP Slogan FIR, Ads Case, Sets 24-Hour Custody Rule
Tamil Nadu Government Allows Six Daily Film Shows Starting at 6 AM
Ranji Trophy: How Nagwaswalla, Gaja, and Patel Put Gujarat in Control Against Kerala
Fielding Lapses in Kanpur Show Why Uttar Pradesh Cannot Rely Solely on Batting Power
Ashok Leyland share price jumps 11.65% on 23% rise in October CV sales 




























